Medical artificial intelligence company Shukun Technology announced the completion of 200 million yuan in Series B1 round of financing. This round was led by BOC International with participation from CCB International Healthcare Fund, existing investors China Creation Ventures and Huagai Capital.
Nanyan Information Technology, a third-party global insurance technology platform, recently announced that it has obtained over 100 million yuan in B2 round of financing, led by BOC International, Bluerun Ventures and other old shareholders.
Ocular drug developer Cloudbreak Therapeutics has recently completed a new round of financing at RMB180 million, led by Chinese venture capital firm V-Capital.Yuanda Pharmaceutical, BOC International and Haoyue Capital poured money into the new round. In October 2018, the company secured its Series A of RMB 110 million by Huayi Capital exclusively.